Ashley S. Harms, PhD, is an assistant professor at the University of Alabama at Birmingham (UAB) in the Department of Neurology and the Center for Neurodegeneration and Experimental Therapeutics. As a dedicated neuroimmunologist, Dr. Harms studies the cellular and immunological mechanisms underlying the initiation and progression of alpha-synucleinopathy disorders, with emphasis on antigen presentation. Utilizing novel genetic and viral model approaches to study the role of immune cell subsets, her lab focuses on how the protein alpha-synuclein contributes to microglial activation, peripheral immune cell infiltration, and subsequent activation of the immune response in Parkinson’s disease and multiple system atrophy.
Co-PI (Core Leadership)
Ashley Harms, PhD
University of Alabama at Birmingham
Ashley S. Harms, PhD, is an assistant professor at the University of Alabama at Birmingham (UAB) in the Department of Neurology and the Center for Neurodegeneration and Experimental Therapeutics. As a dedicated neuroimmunologist, Dr. Harms studies the cellular and immunological mechanisms underlying the initiation and progression of alpha-synucleinopathy disorders, with emphasis on antigen presentation. Utilizing novel genetic and viral model approaches to study the role of immune cell subsets, her lab focuses on how the protein alpha-synuclein contributes to microglial activation, peripheral immune cell infiltration, and subsequent activation of the immune response in Parkinson’s disease and multiple system atrophy.
